Article
Telomere length as a biomarker of early cumulative burden of metabolic syndrome components.
Diabetes research and clinical practice - 1 Aug 2026
Millán Andrea Liliana, Rojo Mailén, Duarte Alejandra, Pérez Hernán, López Ariel Pablo, Frechtel Gustavo Daniel
Abstract excerpt
AIMS: This study evaluated telomere length (TL) as a biomarker of cumulative metabolic dysfunction. We assessed the association between TL and Metabolic Syndrome (MS), its individual components, and their clustering, while comparing obesity phenotypes to evaluate TL's utility in stratifying biological risk during the transition to metabolic impairment. METHODS: In 331 participants, TL was measured by qPCR....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.